159 related articles for article (PubMed ID: 32878998)
1. Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.
Didonna A; Canto Puig E; Ma Q; Matsunaga A; Ho B; Caillier SJ; Shams H; Lee N; Hauser SL; Tan Q; Zamvil SS; Oksenberg JR
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23742-23750. PubMed ID: 32878998
[TBL] [Abstract][Full Text] [Related]
2. The novel multiple sclerosis susceptibility gene ATXN1 regulates B cell receptor signaling in B-1a cells.
Ma Q; Didonna A
Mol Brain; 2021 Jan; 14(1):19. PubMed ID: 33478569
[TBL] [Abstract][Full Text] [Related]
3. Ataxin-1 controls the expression of specific noncoding RNAs in B cells upon autoimmune demyelination.
Ma Q; Didonna A
Immunol Cell Biol; 2023 Apr; 101(4):358-367. PubMed ID: 36681886
[TBL] [Abstract][Full Text] [Related]
4. Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1).
Sánchez I; Balagué E; Matilla-Dueñas A
Hum Mol Genet; 2016 Sep; 25(18):4021-4040. PubMed ID: 27466200
[TBL] [Abstract][Full Text] [Related]
5. Ataxin-1 regulates proliferation of hippocampal neural precursors.
Asher M; Johnson A; Zecevic B; Pease D; Cvetanovic M
Neuroscience; 2016 May; 322():54-65. PubMed ID: 26876606
[TBL] [Abstract][Full Text] [Related]
6. ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
Rousseaux MWC; Tschumperlin T; Lu HC; Lackey EP; Bondar VV; Wan YW; Tan Q; Adamski CJ; Friedrich J; Twaroski K; Chen W; Tolar J; Henzler C; Sharma A; Bajić A; Lin T; Duvick L; Liu Z; Sillitoe RV; Zoghbi HY; Orr HT
Neuron; 2018 Mar; 97(6):1235-1243.e5. PubMed ID: 29526553
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic control of ataxin-1 in multiple sclerosis.
Ma Q; Oksenberg JR; Didonna A
Ann Clin Transl Neurol; 2022 Aug; 9(8):1186-1194. PubMed ID: 35903875
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.
Kim E; Lu HC; Zoghbi HY; Song JJ
Genes Dev; 2013 Mar; 27(6):590-5. PubMed ID: 23512657
[TBL] [Abstract][Full Text] [Related]
9. 5'UTR-mediated regulation of Ataxin-1 expression.
Manek R; Nelson T; Tseng E; Rodriguez-Lebron E
Neurobiol Dis; 2020 Feb; 134():104564. PubMed ID: 31381977
[TBL] [Abstract][Full Text] [Related]
10. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
[TBL] [Abstract][Full Text] [Related]
11. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.
Lam YC; Bowman AB; Jafar-Nejad P; Lim J; Richman R; Fryer JD; Hyun ED; Duvick LA; Orr HT; Botas J; Zoghbi HY
Cell; 2006 Dec; 127(7):1335-47. PubMed ID: 17190598
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.
Goold R; Hubank M; Hunt A; Holton J; Menon RP; Revesz T; Pandolfo M; Matilla-Dueñas A
Hum Mol Genet; 2007 Sep; 16(17):2122-34. PubMed ID: 17599952
[TBL] [Abstract][Full Text] [Related]
13. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
14. Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1.
Lee WS; Al-Ramahi I; Jeong HH; Jang Y; Lin T; Adamski CJ; Lavery LA; Rath S; Richman R; Bondar VV; Alcala E; Revelli JP; Orr HT; Liu Z; Botas J; Zoghbi HY
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35499073
[TBL] [Abstract][Full Text] [Related]
15. Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.
Pérez Ortiz JM; Mollema N; Toker N; Adamski CJ; O'Callaghan B; Duvick L; Friedrich J; Walters MA; Strasser J; Hawkinson JE; Zoghbi HY; Henzler C; Orr HT; Lagalwar S
Neurobiol Dis; 2018 Aug; 116():93-105. PubMed ID: 29758256
[TBL] [Abstract][Full Text] [Related]
16. Intercellular Propagation and Aggregate Seeding of Mutant Ataxin-1.
Huang H; Toker N; Burr E; Okoro J; Moog M; Hearing C; Lagalwar S
J Mol Neurosci; 2022 Apr; 72(4):708-718. PubMed ID: 34826062
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17.
Kim E; Lee Y; Choi S; Song JJ
Biochem Biophys Res Commun; 2014 Jul; 449(4):399-404. PubMed ID: 24858692
[TBL] [Abstract][Full Text] [Related]
18. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1.
Ding Y; Adachi H; Katsuno M; Sahashi K; Kondo N; Iida M; Tohnai G; Nakatsuji H; Sobue G
Neuroscience; 2016 Jul; 327():20-31. PubMed ID: 27058144
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of brain region-specific kinases potentiates neurological rescue in Spinocerebellar ataxia type 1.
Lee WS; Lavery L; Rousseaux MWC; Rutledge EB; Jang Y; Wan YW; Wu SR; Kim W; Al-Ramahi I; Rath S; Adamski CJ; Bondar VV; Tewari A; Soleimani S; Mota S; Yalamanchili HK; Orr HT; Liu Z; Botas J; Zoghbi HY
EMBO J; 2021 Apr; 40(7):e106106. PubMed ID: 33709453
[TBL] [Abstract][Full Text] [Related]
20. Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.
Edamakanti CR; Do J; Didonna A; Martina M; Opal P
J Clin Invest; 2018 Jun; 128(6):2252-2265. PubMed ID: 29533923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
